Focal segmental glomerulosclerosis with a mutation in the mitochondrially encoded NADH dehydrogenase 5 gene: A case report

Autor: Kei Murayama, Masakiyo Wakasugi, Ikuo Nukui, Yasushi Okazaki, Yukiko Yatsuka, Yoshihito Kishita, Tsukasa Naganuma, Hiroshi Kitamura, Yoshimi Jinguji, Toshiyuki Imasawa

Publikováno v: Molecular Genetics and Metabolism Reports. 35:100963

Background: NADH dehydrogenase 5 (ND5) is one of 44 subunits forming Complex I in the mitochondrial respiratory chain. Therefore, a mitochondrially encoded ND5 (MT-ND5) gene mutation causes mitochondrial oxidative phosphorylation (OXPHOS) disorder, r

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15ad3ec15eb31445e3a6bb26f6751a19
https://doi.org/10.1016/j.ymgmr.2023.100963

Febuxostat Therapy for Patients With Stage 3 CKD and Asymptomatic Hyperuricemia: A Randomized Trial

Autor: Kenjiro Kimura, Tatsuo Hosoya, Shunya Uchida, Masaaki Inaba, Hirofumi Makino, Shoichi Maruyama, Sadayoshi Ito, Tetsuya Yamamoto, Yasuhiko Tomino, Iwao Ohno, Yugo Shibagaki, Satoshi Iimuro, Naohiko Imai, Masanari Kuwabara, Hiroshi Hayakawa, Hiroshi Ohtsu, Yasuo Ohashi, Seiichi Matsuo, Hisashi Yamanaka, Tadao Akizawa, Tamio Teramoto, Hiroshi Kasanuki, Kenichi Yoshimura, Hiroshi Sato, Satoshi Horikoshi, Syoichi Maruyama, Masahiko Inaba, Yuji Moriwaki, Haruhito Uchida, Nagayuki Kaneshiro, Hidekazu Moriya, Yasuhiro Komatsu, Shinya Kaname, Kazunari Hanaoka, Makoto Ogura, Masato Ikeda, Kenji Kasai, Akira Sugiura, Kazushi Takahashi, Kenichiro Kojima, Kosaku Nitta, Hirofumi Tamai, Hiroshi Nagaya, Senji Okuno, Ryusuke Kakiya, Hiroya Takeoka, Kyouji Hirata, Kenichiro Asano, Yasuo Fukaya, Yasushi Iwaida, Yasuo Tsuneda, Shigeaki Nishimura, Takeyuki Hiramatsu, Yoshitaka Isaka, Takafumi Ito, Yukio Yuzawa, Kunihiro Yamagata, Tadashi Sofue, Yoshimi Jinguji, Keita Hirano, Kazuhiro Matsuyama, Teruhiko Mizumoto, Yuko Shibuya, Masahiro Sugawara, Moritoshi Kadomura, Yasuaki Teshima, Hiroshi Ohtani, Hiroki Kamata, Susumu Okawara, Masaki Fukushima, Katsumi Takemura, Eriko Kinugasa, Masami Kogure, Yoichi Ehara

Publikováno v: American journal of kidney diseases : the official journal of the National Kidney Foundation. 72(6)

Rationale & Objective Epidemiologic and clinical studies have suggested that urate-lowering therapy may slow the progression of chronic kidney disease (CKD). However, definitive evidence is lacking. Study Design Randomized, double-blind, placebo-cont

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56782b45718cbb95b0b5249dbfc66435
https://pubmed.ncbi.nlm.nih.gov/30470297